Skip to main content

EHP Funds Inc.

SEC CIK
0001927881
Latest filing
Feb 12, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by EHP Funds Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q4 2025 holdings

Shares (Q4 2023)
0
Sold out in Q4 2023
Value
$0
% of portfolio
0.0%
Quarters held
7
Since Q1 2022
Holdings of REGN by EHP Funds Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20230$00.0%−900−100.0%Sold outHolders
Q3 2023900$740.7K0.3%−1,800−66.7%ReducedHolders
Q2 20232,700$1.94M0.6%−1,800−40.0%ReducedHolders
Q1 20234,500$3.70M0.8%−1,200−21.1%ReducedHolders
Q4 20225,700$4.11M0.9%−300−5.0%ReducedHolders
Q3 20226,000$4.13M0.9%+200+3.4%AddedHolders
Q2 20225,800$3.43M0.6%−600−9.4%ReducedHolders
Q1 20226,400$4.47M0.7%–No prior filingHolders